Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.16 | 31.49 |
| PEG Ratio (TTM) | -0.02 | 1.78 |
| P/S Ratio (TTM) | 1.10 | 2.24 |
| P/B Ratio (TTM) | 0.59 | 2.82 |
| P/FCF Ratio (TTM) | -0.15 | 15.75 |
| Price to 5YR AVG Earnings Ratio | N/A | 8.40 |
| Price to 5YR AVG FCF Ratio | N/A | 46.54 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.61% | 7.34% |
| ROE (TTM) | -43.14% | 13.06% |
| Net Profit Margin (TTM) | -41.20% | 8.11% |
| ROIC 5YR AVG | N/A | 11.95% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | -1,698.69% | N/A |
| Revenue | N/A | 252.29% | N/A |
| Net Income | N/A | -1,641.85% | N/A |
| Cash Flow | N/A | 490.36% | N/A |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.28 | 2.43 |
| Quick Ratio (TTM) | 0.28 | 2.37 |
| D/E Ratio (TTM) | 4.01 | 0.29 |
| Interest Coverage (TTM) | 0.13 | 17.46 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | N/A | 4.75 |
| LTL to 5YR AVG FCF | N/A | 5.80 |
| Shares Outstanding Growth 5YR AVG | N/A | 100.69% |